Pardaxin, an antimicrobial peptide secreted by the Red Sea flatfish Pardachirus marmoratus, inhibits proliferation and induces apoptosis of human cancer cell lines. However, the underlying molecular mechanisms are only partially understood at present. In this study, we used proteomic approaches and network reconstruction to clarify the mechanism of pardaxin-induced apoptosis in human cervical carcinoma HeLa cells. We identified that pardaxin-regulated proteins predominantly function in the unfolded protein response, oxidative stress and cytoskeletal distribution. Molecular examination of signal transduction and cellular localization demonstrated that the activator protein-1 transcription factor was activated, which eventually caused apoptosis via both caspase-and apoptosis-inducing factor-dependent pathways. Scavenging of reactive oxygen species (ROS) alleviated c-Jun activation, and small interfering RNA knockdown of c-Jun abrogated pardaxin-induced caspase activation and cell death, thereby implicating ROS and c-Jun in pardaxin-induced apoptosis signaling. In summary, this study provides the first proteininteracting network maps and novel insights into the biological responses and potential toxicity of pardaxin.
Introduction
Antimicrobial peptides (AMPs) have evolutionarily conserved functions and can be produced by almost all organisms (1) . As immunomodulators that target pathogens, AMPs enhance the innate immune response of hosts by acting as the first line of defense (2, 3) . Based on differences in the physical properties of cell membranes of normal cells and pathogens, AMPs are usually toxic to bacteria, fungi, viruses, mycoplasma and, in some cases, cancer cells (3) . In general, AMPs bind to anionic and hydrophobic membranes of pathogens through electrostatic or hydrophobic interactions (4) . After attaching to a membrane, AMPs insert themselves into membrane bilayers to form pores, or penetrate lipid bilayers to disrupt intracellular reactions, attacking cells in a lytic way or by disrupting homeostasis (4, 5) .
Pardaxin is an AMP secreted by the Red Sea flatfish Pardachirus marmoratus (6) . In addition to its utilization as a shark repellent, pardaxin has been shown to possess potent antibacterial, antiviral and antifungal activities (7, 8) . Recently, we revealed that pardaxin displays high-efficacy anticancer activity by inducing apoptosis in human cervical carcinoma HeLa cells (9) . We also demonstrated that pardaxin activated caspase-3 and caspase-7 activities, disrupted mitochondrial membrane potential (MMP) and caused the accumulation of reactive oxygen species (ROS) produced by fibrosarcoma HT-1080 cells (10) . Scavenging of ROS production and inhibition of caspase activities reduced pardaxin-induced effects (10) .
Apoptosis is a cell death process that involves specific morphological changes, including plasma membrane blebbing, cell shrinkage, chromatin condensation, nuclear fragmentation and chromosomal DNA fragmentation (11) . Mitochondria play a central role in initiating apoptosis by releasing small mitochondrion-derived activator of caspases (SMAC) and cytochrome (Cyt) c into the cytosol. Cytosolic small mitochondrion-derived activator of caspases and Cyt c bind to the inhibitor of apoptosis proteins and apoptotic protease activating factor (Apaf)-1, respectively, to cooperatively activate caspase cascades and execute apoptosis. Another distinct apoptotic pathway is caspase independent, which is caused by the release of apoptosisinducing factor (AIF) from intermembrane spaces of mitochondria; translocation of AIF to nuclei triggers chromatin condensation and DNA fragmentation (12) .
The endoplasmic reticulum (ER) is a continuous membrane network in which secreted and membrane proteins mature with the assistance of ER luminal chaperone proteins, such as glucoseregulated protein, 78 kDa (GRP78/BiP), GRP94 and calreticulin. Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR), which causes an expansion of the ER membrane, upregulation of components involved in protein folding and quality control and attenuation of protein synthesis, to restore ER capacity. When ER homeostasis cannot be restored, a prolonged UPR can lead to apoptosis through activation of CHOP and caspase-3. Elevated CHOP transcription induces Bim, a proapoptotic BH3-only B-cell lymphoma 2 family member, which activates apoptosis (13) .
The ER is a redox environment in which reduced and oxidized disulphide bonds are formed, which helps ensure that proteins assume the correct conformation during protein folding. Disruptions to the balance of the redox system through accumulation of ROS or inhibition of antioxidant-producing systems triggers the UPR, thereby helping cells adapt to oxidative stress (14) . Activation of c-Jun contributes to several cellular responses, including apoptosis, proliferation and differentiation. The outcome of c-Jun N-terminal kinase (JNK)/cJun signaling strongly depends on the cell type and cellular context. Accumulation of ROS predominantly activates the mitogen-activated protein kinases (MAPKs), JNK and p38 MAPK, which result in c-Jun phosphorylation and apoptosis (15) . ROS production activates c-Jun on one hand and induces the UPR on the other. Both c-Jun phosphorylation and UPR signaling contribute to apoptosis, when the cell cannot overcome oxidative stress.
In this study, we demonstrate the efficacy of pardaxin against several cervical cancer cell lines and determine the predominant effects of inducing apoptotic cell death in HeLa cells. By inducing oxidative stress, the UPR and phosphorylation of c-Jun, pardaxin triggered both caspase-and AIF-dependent apoptotic pathways. As oxidative stress, the UPR and c-Jun activation are double-edged swords, here we emphasize that pardaxin exhibits high cytotoxicity efficacy and may therefore be a promising anticancer drug that induces apoptosis in cervical cancer cells by regulating these three cellular modulators.
Materials and methods
A schematic representation of the study design is shown in Supplementary  Figure 1 , available at Carcinogenesis Online, and the methods are described in detail below.
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Before use, the peptide was dissolved in deionized water at a concentration of 1 mg/ml and sterilized by filtration through a 0.2 µm filter.
Cell lines and cell culture
Human cervical carcinoma (HeLa, HeLa229, CaSki and C33A) and human fibroblast (MRC-5) cell lines were purchased from the Bioresource Collection and Research Center (Hsinchu, Taiwan). The cell lines were maintained at 37°C in a humidified atmosphere of 5% CO 2 and 95% air in modified Eagle's medium supplemented with 2 mM l-glutamine, 0.1 mM non-essential amino acids and 10% heat-inactivated fetal bovine serum.
Cell viability assay
The cytotoxicity of pardaxin was estimated by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay using a previously reported method (16) . Cells were plated in 96 well microplates at an initial density of 2500 cells per well in complete medium. After overnight incubation, the medium was replaced with experimental medium containing various concentrations of pardaxin. At the end of the experiment, 20 μl of a combined MTS/phenazine methosulfate solution (1:1) was added to each well for an additional 2 h. The optical density at 490 nm was measured using a microplate reader. Values were expressed as a percentage relative to those obtained in the untreated controls. All experiments were performed in triplicate and were repeated three times.
Assessment of apoptosis by flow cytometry
Pardaxin-induced apoptosis was determined by a two-color analysis of annexin V (AV)-fluorescein isothiocyanate (FITC) binding and propidium iodide (PI) uptake by flow cytometry, according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). Cells were harvested and washed twice in cold phosphate-buffered saline (PBS), stained with V-FITC and PI for 30 min in the dark and analyzed with a Cytomics FC 500 flow cytometer (Beckman Coulter, CA) equipped with an air-cooled argon laser with emission at 488 nm. Data were analyzed using FlowJo software (TreeStar, Ashland).
Morphological detection of apoptosis
Apoptotic morphological changes in cells were detected by staining with Hoechst 33342. In brief, cells were washed with PBS and then fixed in 4% paraformaldehyde for 15 min at 37°C. Fixed cells were stained with Hoechst 33342 (1 μg/ml in PBS) for 15 min at 37°C in the dark, then examined by fluorescence microscopy.
Evaluation of the MMP (ΔΨm)
The MMP was measured with JC-1 dye (Invitrogen). Briefly, cells were harvested and washed twice in cold PBS and resuspended in PBS containing 2 μm JC-1. After 30 min of incubation at 37°C in the dark, cells were washed with PBS and resuspended in 500 μl PBS. Stained cells were analyzed on a Cytomics FC 500 flow cytometer (Beckman Coulter) to detect green fluorescence at excitation/emission wavelengths of 485/530 nm and red fluorescence at excitation/emission wavelengths of 550/595 nm.
Measurement of intracellular ROS
Intracellular ROS levels were measured using a cell-permeable fluorescent dye, H 2 DCFDA (Invitrogen). Cells were harvested, washed twice in cold PBS and incubated with 10 μM H 2 DCFDA for 30 min at 37°C in the dark. Stained cells were analyzed with a Cytomics FC 500 flow cytometer (Beckman Coulter). The mean fluorescence intensity was obtained by histogram statistics using WinMDI 2.9.
Caspase-3/-7 activity assay
Caspase-3/-7 activity was measured with the CellEvent™ caspase-3/-7 Green Detection Reagent (Invitrogen). On cleavage by activated caspase-3/-7, the probe becomes fluorescent and free to bind to DNA. Cells were incubated with 5 μM CellEvent™ caspase-3/-7 green detection reagent in complete medium for 30 min at 37°C in the dark. Stained cells were observed by fluorescence microscopy. Fluorescent expression levels were quantified using ImageJ software.
Two-dimensional electrophoresis
For two-dimensional electrophoresis, isoelectric focusing (IEF) was performed using the Bio-Rad Protean IEF Cell (Bio-Rad, Hercules, CA). Total proteins at 350 μg were mixed with 300 μl rehydration buffer containing 7 M urea, 2 M thiourea, 4% [(3-cholamidopropyl)-dimethyl-ammonio]1-propanesulfonate, 65 mM dithioerythritol, 1% carrier ampholytes (IPG buffer) and 0.002% bromophenol blue. Mixtures were loaded onto a 17 cm IPG ReadyStrip pH 4-7 (Bio-Rad). IEF parameters for separation were set to 50 μA per strip at 20°C, with a rehydration step for 14 h. IEF was carried out as follows: 2 h at 100 V, 30 min at 250 V, 30 min at 500 V, 30 min at 1000 V and 30 min at 4000 and 8000 V for 65 000 Vh. The focused strips were reduced with 65 mM dithioerythritol and alkylated with 55 mM iodoacetamide. Second-dimension separation was performed on a linear-gradient 10-15% polyacrylamide gel. The protein gel was fixed in 10% methanol/7% acetic acid and stained using the SYPRO® Ruby method (Invitrogen). Gels were then scanned using a Molecular Imager FX (Bio-Rad) and analyzed using the Prodigy SameSpot 2D software package (Nonlinear Dynamics, Newcastle, UK).
In-gel digestion and protein identification
Protein spots of interest were excised, destained and subjected to tryptic in-gel digestion as described previously (17) . Gel pieces were destained with a 1:1 (vol/vol) solution containing 50 mM ammonium bicarbonate and acetonitrile and dehydrated twice with acetonitrile. After the gel pieces were air dried, proteins were digested with sequence-grade trypsin (Promega, Madison, WI) at 37°C overnight. The digested peptides were extracted from the gel with 2% trifluoroacetic acid in 100% acetonitrile. The extracts were evaporated to dryness, and the protein fragments were dissolved in 0.1% trifluoroacetic acid, well mixed with 10 μg/ml α-cyano-4-hydroxycinnamic acid (1:1, vol/vol), and directly spotted onto the sample plate of a matrix-assisted laser desorption/ionization (MALDI) quadrupole time-of-flight (Q-TOF) mass spectrometer (MS).
MALDI-TOF MS and MS/MS were performed on a dedicated Q-TOF Ultima MALDI instrument (Micromass, Manchester, UK), with fully automated data-directed acquisition using a predefined probe motion pattern, and a peak intensity threshold for switching over from the MS survey scan to MS/ MS, and from one MS/MS to the other. All individual MS/MS data points thus generated from a particular sample well were then output as a single MASCOTsearchable peak list file. Within each sample well, parent ions that met the predefined criteria (any peak within the m/z 80-3000 range with an intensity >10 counts ± inclusion/exclusion list) were selected for collision-induced dissociation MS/MS using argon as the collision gas, and a mass-dependent rolling collision energy of ±5 V until the end of the probe pattern was reached (all details are available at http://proteome.sinica.edu.tw). At a laser firing rate of 10 Hz, individual spectra from a 5 s integration period acquired for each MS survey and MS/MS performed were combined, smoothed, deisotoped (fast option) and centroided using Micromass ProteinLynx™ Global Server (PGS) 2.0 data processing software. Proteins were subsequently identified using the MASCOT (http://www.matrixscience.com) search engine against the Swiss-Prot release 2011_06 database, as described previously. Database search parameters included the following: only tryptic peptides with up to one missing cleavage site were allowed, modifications were carbamidomethylation (C) and oxidation of methionine, the peptide mass tolerance was ±50 p.p.m. and the fragment mass tolerance was ±0.25 Da. For positive identification, the score of the result of [−10 log(P)] had to exceed the significance threshold level (P < 0.05).
Transmission electron microscopy
Cells were collected, washed with PBS and fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate-HCl buffer (Sigma, St Louis, MO) for 2 h at 4°C. Next, cells were washed with 0.1 M sodium cacodylate-HCl buffer three times, postfixed for 2 h with 1% osmium tetroxide in 0.1 M sodium cacodylate-HCl buffer, and washed again with 0.1 M sodium cacodylate-HCl buffer. Cells were dehydrated through graded ethanol concentrations with final dehydration using propylene oxide. After dehydration, cells were embedded in epoxy resin. Samples were cut into ultrathin sections, double stained with uranium and lead citrate and observed under transmission electron microscopy operating at 75 kV (Hitachi H-7000, Tokyo, Japan).
Immunofluorescence staining Cells were fixed in 4% paraformaldehyde in PBS for 15 min at room temperature, washed twice with PBS and permeabilized with 0.25% Triton X-100 in PBS for 10 min. Fixed cells were incubated with the blocking reagent (10% bovine serum albumin in PBS) for 30 min at room temperature. Cells were then incubated overnight at 4°C with primary antibodies in 10% bovine serum albumin in PBS. The specific binding of primary antibodies was visualized by incubation with Alexa-488-conjugated immunoglobulin G for 30 min at room temperature, and cells were finally washed and mounted using the ProLong Gold antifade reagent with 4′,6-diamidino-2-phenylindole (DAPI). The primary antibodies were as follows: anti-c-Jun (Abcam, Cambridge, MA), anti-cFos (Cell Signaling Technology, Beverly, MA), anti-AIF (Abcam), anti-CHOP (Santa Cruz Biotechnology, Santa Cruz, CA) and anti-ATF6 (Santa Cruz). Fluorescent signals and bright-field images were captured using an inverted fluorescence microscope.
Western blot analysis
Cells were harvested, washed twice with ice-cold PBS and lysed in lysis buffer containing protease inhibitor cocktail. The concentration of extracted proteins was determined using the Bio-Rad protein assay reagent. Protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After being transferred onto polyvinylidene difluoride membranes and blocked with Small interfering RNA transfection ON-TARGETplus SMARTpool small interfering RNAs (siRNAs) targeting c-Jun were purchased from Dharmacon Research (Lafayette, CO). HeLa cells were seeded onto 12 well plates at 50-70% confluency and transfected with 50 pmol c-Jun siRNA or control siRNA using Lipofectamine 2000 (Invitrogen). After transfection for 36 h, cells were incubated in the presence or absence of pardaxin for 12 h, and cell viability or caspase-3/-7 activity was measured.
Statistical analysis
Data are shown as the mean ± standard deviation (SD). Statistical comparisons were performed using Student's t-test, and differences between groups were considered significant at a P < 0.01. For cell viability, variance between dosages was analyzed by analysis of variance followed by Scheffe's test, and variance between treated cells and the untreated control was analyzed by Student's t-test.
Results

Pardaxin caused the death of cervical cancer cells
We observed that treatment with pardaxin caused dose-(0-20 µg/ml) and time-dependent (3-24 h) death of HeLa, HeLa299, CaSki and C33A human cervical cancer cells. Pardaxin at 15 µg/ml significantly reduced viability of all four cell lines compared with the control within as little as 3 h (black bars) of exposure ( Figure 1 ). Fifty percent inhibitory concentration (IC 50 ) values were calculated by sigmoid-curve fitting (Supplementary Table 1 , available at Carcinogenesis Online). The average IC 50 values at 3-24 h posttreatment with pardaxin for HeLa, HeLa299, CaSki and C33A cells were 13.85 ± 1.24, 14.63 ± 1.37, 14.87 ± 0.42 and 14.14 ± 0.94 μg/ml, respectively. At 12 h, pardaxin exhibited the highest efficacy in HeLa cells (IC 50 of 12.96 µg/ml). To confirm that the cytotoxic effect of pardaxin is limited to cervical cancer cells, we measured the cell viability of MRC-5 fibroblasts treated with 13 μg/ml pardaxin for 12 h. We report that pardaxin caused a decrease in the viability of HeLa, but not MRC-5 cells, suggesting selectivity of pardaxin for neoplastic cells (Supplementary Figure 2 , available at Carcinogenesis Online).
Pardaxin-induced apoptosis in HeLa cells
To determine the type of cell death induced in HeLa cells by pardaxin, we measured the percentage of apoptotic HeLa cells using FITCconjugated AV/PI and flow cytometry. Simultaneous staining of cells with FITC-AV (green fluorescence) and the non-vital dye PI (red ( Figure 2B and C) . These results indicate that pardaxin induces apoptotic cell death in HeLa cells.
Loss of MMP acts as a key regulator of the intrinsic apoptosis pathway (18) , and as such, we examined whether pardaxin causes mitochondrial dysfunction in HeLa cells by measuring MMP using a JC-1 probe. MMP in HeLa cells significantly decreased after 3 h of treatment with 13 μg/ml pardaxin and continued to decrease over time ( Figure 2D ). When cells are induced to undergo apoptosis, AIF translocates from the mitochondrial intermembrane space to the cytosol and nuclei in a caspase-independent manner (19) . In addition, loss of outer membrane integrity results in a massive release of Cyt c from mitochondria in response to caspase activation (18) . To assess the release of Cyt c and AIF, we measured the amounts of these proteins in cytosolic and nuclear fractions. Furthermore, we examined AIF translocation by immunofluorescence staining. We found that pardaxin treatment resulted in AIF translocation to nuclei ( Figure 2E and F) and increased Cyt c in the cytosol ( Figure 2F ), indicating that pardaxin triggers caspase-dependent and caspase-independent apoptosis.
A decrease in MMP suggested that caspase-dependent apoptosis may occur in response to pardaxin. Caspase-3/-7 activation was detected by cleavage of a DNA probe containing the sequence DEVD. Of HeLa cells treated with 13 μg/ml pardaxin, 52.74% exhibited positive fluorescent signals in nuclei, indicating caspase-3/-7 activation ( Figure 2G and H) .
Identification of differentially expressed proteins in pardaxintreated HeLa cells
To characterize the effects of pardaxin on cervical cancer cells, we performed two-dimensional electrophoresis and MALDI-Q-TOF to identify differentially expressed proteins in pardaxin-treated HeLa cells ( Figure 3A) . Protein expression profiles were analyzed, and spots with >1.4-fold change in expression were identified (Supplementary Table 2 , available at Carcinogenesis Online). Among the differentially expressed proteins, 14 proteins were decreased ( Figure 3B ) and 13 proteins were increased ( Figure 3C ). Two of the downregulated proteins (RhoGDI and protein DJ-1) and two of the upregulated ones (Grp94 and calmodulin) were randomly selected to validate the proteomic results by western blotting ( Figure 3D ).
Pardaxin-induced protein folding, free-radical scavenging and cytoskeleton-associated protein alterations in HeLa cells
To associate biological functions with pardaxin-modulated proteins, we applied the software tool, Ingenuity Pathway Analysis. The list of identified proteins and corresponding multiples of change were uploaded to the Ingenuity Pathway Analysis software (Ingenuity Systems, Redwood City, CA) for core analysis. According to the biofunction analysis, the top networks with associated molecular and cellular functions were protein folding, free-radical scavenging and cytoskeletal rearrangement (Supplementary Figure 4A , available at Carcinogenesis Online). Protein-folding processes mainly take place in the ER. Disruption of protein folding in the ER triggers the UPR to recover protein-folding capacity. Failure to restore ER homeostasis causes prolonged UPR, which leads to apoptosis. Induction of endogenous free-radical scavengers or antioxidants is beneficial under oxidative stress, which may be caused by ROS accumulation and imbalances between the prooxidative and antioxidant systems. MAPKs, such as JNK (20) and p38MAPK, are preferentially activated in response to ROS production, linking oxidative stress to apoptosis signaling (21) . Cytoskeletal modification, arrangement and distribution are highly modulated by activated caspases during apoptosis. The initial process of apoptosis in cells involves partial detachment from the extracellular matrix, and the formation of a rounded morphology as a consequence of a loss of stress fibers and reorganization of actin into a peripheral ring (22) . In summary, enrichment of all three of these distinct molecular and cellular functions suggests that pardaxin triggers apoptosis.
In addition, we found that upstream regulators of upregulated proteins, including AP-1, c-Fos and Nrf-2, were highly connected (Supplementary Figure 4B , available at Carcinogenesis Online), suggesting that cooperative transcriptional regulation may have taken place. The transcription factor AP-1 consists of c-Jun and c-Fos. Activation of AP-1 implies increased JNK activity, whereas activation of Nrf-2 implies the initiation of antioxidant production (20) . Both JNK and antioxidants undergo molecular regulation in response to oxidative stress; this suggests that pardaxin may cause an accumulation of ROS that contributes to oxidative stress.
To dissect the function of pardaxin in HeLa cells, we analyzed upregulated and downregulated proteins by gene ontology annotation, and discovered that pardaxin resulted in increased levels of UPR proteins (Supplementary Figure 5A , available at Carcinogenesis Online) and decreased levels of proteins involved in oxidative stress (Supplementary Figure 5B , available at Carcinogenesis Online). Overall, our results indicate that pardaxin caused oxidative stress and activated the UPR, which resulted in cytoskeletal disassembly and apoptosis.
Pardaxin caused cytoskeletal rearrangement
We proceeded to confirm the effect of pardaxin on cytoskeletal rearrangement, a process which is related to the initiation of apoptosis. Actin filaments and microtubules are the two major components of the cytoskeleton and they control cell shape and movement. To monitor changes in the cytoskeleton, we examined the immunofluorescence of actin filaments and microtubules, using phalloidin and an α-tubule antibody, respectively. Interestingly, we observed that strong stress fiber bundles predominantly formed along cell edges in the presence of pardaxin, whereas untreated cells harbored thinner actin fibers both in central areas and at the edges of cells ( Figure 4A ). In addition, microtubules exhibited strong perinuclear staining and fragmentation in the cytoplasm after 12 h of pardaxin treatment ( Figure 4A ), implying that failure of cell division may have occurred.
Pardaxin elevated UPR-regulated proteins
To examine whether pardaxin triggered the UPR, we measured levels of UPR proteins and monitored the morphology of the ER, where proteins are folded. Transmission electron microscopy analysis demonstrated that the ER was dilated in response to 6 h of pardaxin treatment ( Figure 4B ), prior to the emergence of typical signs of apoptosis, such as nuclear condensation. Western blot analysis indicated that the UPR was activated within 3 h of pardaxin treatment, as demonstrated by increases in PERK, calnexin and PDI proteins and by eIF2α phosphorylation ( Figure 4C ). Furthermore, we found that pardaxin treatment induces translocation of two transcription factors, ATF6 ( Figure 4D ) and CHOP ( Figure 4E ), to nuclei; these transcription factors mediate apoptotic signaling from the UPR. These data indicate that pardaxin causes ER stress, which may account for the increase in apoptotic cells.
Pardaxin repressed ROS-associated enzymes and stimulated ROS generation by HeLa cells
Among the identified downregulated proteins, the gene ontology term 'cellular response to hydrogen peroxide' was enriched, indicating that this process may be closely associated with ROS signaling (Supplementary Figure 5B , available at Carcinogenesis Online). Hence, we reasoned that pardaxin treatment may cause aberrant ROS signaling in cervical cancer cells. We used H 2 DCFDA staining to measure intracellular ROS production by HeLa cells at the indicated time points in response to 13 μg/ml pardaxin treatment. As expected, pardaxin treatment enhanced ROS generation within 1 h compared with the untreated control (P < 0.01; Figure 4F ). We next examined the response of an oxidative response transcription factor, Nrf-2, to pardaxin treatment. Western blot revealed that levels of Nrf-2 were increased by pardaxin ( Figure 4G ). These data imply that pardaxin may induce ROS accumulation through suppressing the expression of ROS-associated enzymes, thus causing oxidative stress.
Pardaxin promoted AP-1 phosphorylation and translocation to nuclei AP-1 consists of two transcription factors, c-Jun and c-Fos, and regulates cell growth, proliferation, transformation and apoptosis. The Ingenuity Pathway Analysis transcription factor analysis predicted that c-Jun and c-Fos were costimulated (Supplementary Figure 4B , available at Carcinogenesis Online). To validate activation of AP-1, we examined the phosphorylation and nuclear localization of c-Jun and c-Fos. In response to pardaxin treatment, both c-Jun and c-Fos were phosphorylated and translocated to nuclei ( Figure 5A and Supplementary Figure 6 , available at Carcinogenesis Online). Because c-Jun is phosphorylated by JNK, we next confirmed whether JNK was activated by phosphorylation under the same conditions. Indeed, JNK was phosphorylated after at least 3 h of pardaxin treatment ( Figure 5B ). Phosphorylation of JNK and c-Jun was dramatically enhanced, suggesting that pardaxin may induce apoptosis via stimulation of the JNK pathway.
Pardaxin-triggered c-Jun activation was mediated via ROS production
It was previously reported that increased ROS levels contribute to AP-1 activation (23); thus, we next examined whether pardaxininduced c-Jun phosphorylation was mediated by ROS. To address this question, we pretreated cells with N-acetyl-l-cysteine (NAC), an ROS scavenger which helps protect against oxidative stress, before pardaxin treatment. Pardaxin-induced phosphorylation and translocation of c-Jun were significantly attenuated by treatment with 10 mM NAC for 1 h ( Figure 5C ), indicating that pardaxin activates AP-1 via ROS production.
Pardaxin-induced cytotoxicity and caspase-3/-7 activation are mediated by c-Jun
To determine whether c-Jun is involved in pardaxin-mediated cytotoxicity, we examined the viability of c-Jun knockdown cells in response to pardaxin. About 31% of control siRNA-treated HeLa cells survived pardaxin treatment ( Figure 5D , white bars), whereas >65% of c-Junknockdown cells survived ( Figure 5D , black bars), indicating that pardaxin-triggered apoptosis may be mediated by c-Jun. We also investigated the involvement of c-Jun in the pardaxin-mediated increase in caspase cascade signaling. Knockdown of c-Jun caused a decrease in caspase-3/-7 activation by pardaxin. Only 31% of pardaxin-treated cells exhibited caspase-3/-7-activation under c-Jun knockdown conditions compared with 55% of control siRNA cells ( Figure 5E ). These results indicate that c-Jun participates in pardaxin-mediated apoptosis.
Discussion
In this study, we have used a proteomic approach to uncover molecular explanations for pardaxin-induced apoptosis in cervical cancer HeLa cells (Supplementary Figure 1 , available at Carcinogenesis Online). We identified that pardaxin-regulated proteins predominantly function in the UPR, oxidative stress and cytoskeletal distribution (Figure 4) . Examination of signal transduction and cellular localization at the molecular level demonstrated that c-Jun activation contributes to pardaxin-activated caspase-3/-7 in apoptotic signaling ( Figure 5 ).
In general, AMPs are peptides composed of cationic and amphipathic amino acids. AMPs can directly interact with anionic membranes, which most bacteria possess, by electrostatic binding, and subsequently disrupt the membrane structure or inhibit metabolism, thus killing the pathogen (2,24,25) . Membrane lipid compositions greatly differ between bacteria and animal cells (26) . The compositions of the inner and outer membrane (E) Caspase-3/-7 activity was assayed using the CellEvent™ Caspase-3/7 Green detection reagent, and image data were acquired by fluorescent microscopy from three random fields of view. Cell viability and caspase activity data were normalized to the untreated group with control siRNA. Asterisks indicate significant differences from control siRNA-harboring cells, at P < 0.001.
Scale bars indicate 50 μm. (B) HeLa cells were incubated in the presence and absence of 13 μg/ml pardaxin for 3 h, then fixed, and processed for electron microscopy. Cells were imaged at ×20 000 magnification. Electron microscopic analysis of pardaxin-treated HeLa cells revealed a dilated ER. Black arrows indicate the ER. Scale bars indicate 500 nm. (C) Expression of ER stress-related proteins in pardaxin-treated and untreated HeLa cells was determined by western blot. Protein expression levels were quantified by densitometry and normalized to β-actin. ← leaflets are also distinct. In animal cells, the major components of the outer leaflet are phosphatidylcholine, sphingomyelin, cholesterol and a variety of glycolipids (27) . In contrast, the inner leaflet is composed of acidic phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol (27) . Such a structure allows only weak hydrophobic interactions with cationic AMPs. On the other hand, bacterial cell membranes are enriched with neutral phosphatidylethanolamine, and acidic phosphatidylglycerol and cardiolipin, which enable electrostatic and hydrophobic binding to cationic AMPs (28) .
During transformation, the total amount of phospholipids increases (29) . Tumor cells often reside in acidic environments, as their rapid duplication is supported by oxidative glycolysis, producing enormous levels of lactate (30) . As a result, elevated phospholipids may alter the net charge of plasma membranes in acidic environments inhabited by tumor cells. Therefore, amphipathic AMPs may selectively bind to tumor cells, and subsequently penetrate or disrupt their plasma membranes (31) . The different affinities of AMPs for tumor and normal cells result in target specificity for tumor tissues.
Pardaxin is a helical AMP with an overall positive charge, and 45% of its residues are hydrophobic. We demonstrated that pardaxin is cytotoxic to various cervical cancer cells (Figure 1 ), but has only small effects on normal cells (9, 10) , implying that pardaxin is an effective AMP for cancer targeting. The cytotoxicity of pardaxin was identified as arising from apoptotic cell death accompanied by mitochondrial dysfunction, including depletion of the MMP and release of AIF and Cyt c (Figure 2 ). Mitochondrial permeability is a key regulator of intrinsic apoptosis (32) and is under the control of antiapoptotic proteins of the B-cell lymphoma 2 family. Once a death signal is transmitted, B-cell lymphoma 2 proteins are translocated to mitochondria and promote the release of Cyt c and other soluble proteins that reside in the mitochondrial intermembrane space (33) . Our data indicate that pardaxin-induced release of Cyt c may account for activation of caspase-3/-7 ( Figure 2E-H) . Another intermembrane space protein, AIF, was reported to be sufficient to induce caspase-independent apoptosis (19) . We found that AIF was released by mitochondria into the cytoplasm following pardaxin treatment ( Figure 2E and F) . In addition, pardaxin treatment resulted in chromatin condensation, as revealed by Hoechst nuclear staining ( Figure 2B and C) . RhoGDI is upregulated in multiple cancers. Silencing of RhoGDI sensitized cancer cells to chemotherapeutic agent-induced apoptosis (34) , suggesting that RhoGDI plays a critical role in the development of drug resistance in cancer cells. Our proteomic analysis revealed that RhoGDI was decreased by pardaxin treatment ( Figure 3D ). Together, these results indicate that pardaxin-triggered apoptosis involves both caspasedependent and caspase-independent pathways.
To investigate the upstream signals that activate apoptosis, we performed two-dimensional electrophoresis and network analysis, to identify differentially expressed proteins and reveal pardaxinregulated biological functions (Supplementary Figure 4 , available at Carcinogenesis Online). The top enriched function revealed by functional annotation analysis was protein folding, suggesting that the UPR may be induced by pardaxin (Supplementary Figure 5A , available at Carcinogenesis Online). Proteins involved in the UPR reside in the ER, where proteins are synthesized, folded, glycosylated and secreted (35) . The UPR is activated in response to an accumulation of unfolded proteins in the ER, which exhibits a typical stressed morphology of an enlarged and dilated lumen (36, 37) . We showed that pardaxin treatment caused ER dilation, suggesting that pardaxin initiated the UPR ( Figure 4B ). Upregulation of UPR response proteins within 3 h of pardaxin treatment validated the proteomics data ( Figure 4C ). The UPR alleviates stress by upregulating protein folding and an ER-associated degradation pathway, and inhibiting protein synthesis (38) . Western blot analysis revealed that pardaxin treatment increased proteins involved in protein folding, including Grp94, calnexin and PDI, and upregulated levels of PERK and CHOP and phosphorylation of eIF2α, indicating that protein translation was inhibited, consistent with the consequences of UPR activation.
The UPR is induced by various stimuli in cells (38) . Oxidative stress is a product of various stimuli that disrupt protein folding and induce the UPR (39) . A prolonged UPR eventually causes ER stress, accompanied by the release of calcium into the cytosol (38, 40) . A rise in the concentration of cytosolic calcium is modulated by a mitochondrial calcium uniporter into mitochondria, resulting in an increase in mitochondrial calcium (41, 42 ). An overload of mitochondrial matrix calcium can lead to enhanced ROS generation, transition pore permeability and Cyt c release, resulting in apoptosis (42) . ROS, on the other hand, activate the JNK pathway, which also leads to cell apoptosis (14, 43) . We found that NAC pretreatment restored c-Jun activation ( Figure 5C ), and c-Jun knockdown compromised pardaxin-caused cell death and caspase activation ( Figure 5D and E), implying that JNK signaling is downstream of ROS generation and upstream of caspase activation and cell death.
In Figure 6 , we present a model of pardaxin action. We hypothesize that pardaxin selectively targets cancer cells through electrostatic binding, which causes ROS production that results in oxidative stress and activation of the UPR; this in turn induces JNK/c-Jun and PERK/eIF2α/ CHOP signal transduction (44, 45) , which leads to caspase-and AIFdependent apoptotic events (20) , such as loss of the MMP (36), a decrease in RhoGDI (postulated to generate the initial morphology of apoptosis by regulating actin polymerization (22, 46) ) and chromatin condensation (36) . In summary, we have uncovered the molecular mechanisms underlying pardaxin-induced apoptosis. In addition, we have demonstrated the feasibility of combining proteomic approaches with network analysis to reveal the complex biological pathways and dynamic regulatory processes that modulate the effects of AMPs on cancer cells.
Supplementary material
Supplementary Tables 1 and 2 and Figures 1-6 can be found at http:// carcin.oxfordjournals.org/ 
